Browse our articles
Scott Findlay: Could our oral and cardiovascular health link to Alzheimer’s disease?
Scott Findlay, a PhD Student is carrying out a study to find out
New dementia drug – an update
News of the approval of the new Alzheimer’s drug has hit the headlines this week.
Taking part in dementia research: David's story
Despite not having dementia, David still wanted to help others with condition.
Significant breakthroughs in dementia research
Reflecting on the progress dementia research has made
Taking part in dementia research: John’s story
When John was diagnosed with frontotemporal dementia he wanted to learn more about his condition.
New Alzheimer's drug slows cognitive decline by 35 per cent
Donanemab has been shown to reduce cognitive decline in people with early-stage Alzheimer’s disease.